The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Martynova O.O.

Sechenov First Moscow State Medical University (Sechenov University)

Zaharov V.V.

Sechenov First Moscow State Medical University (Sechenov University)

Impairment of attention and executive functions in chronic cerebrovascular disease and Alzheimer’s disease

Authors:

Martynova O.O., Zaharov V.V.

More about the authors

Read: 1812 times


To cite this article:

Martynova OO, Zaharov VV. Impairment of attention and executive functions in chronic cerebrovascular disease and Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;124(4‑2):25‑32. (In Russ.)
https://doi.org/10.17116/jnevro202412404225

Recommended articles:
Cyto­kine status of patients with Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):5-12
Differential diagnosis of Alzheimer’s disease and vascular cognitive diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):26-35
A comprehensive study of Alzheimer’s disease biomarkers in plasma and cere­brospinal fluid. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):43-53
Prospects for treating Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):54-60
Non-invasive biomarkers for early diagnosis of Alzheimer’s disease in bodily fluids. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):8-16
Treatment features of patients with vascular cognitive impairments. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):69-76

References:

  1. Long S, Benoist C, Weidner W. World Alzheimer Report 2023: Reducing dementia risk: never too early, never too late. London, England: Alzheimer’s Disease International. 2023.
  2. Livingston G, Sommerlad A, Orgeta V, et al. Dementia prevention, intervention, and care. Lancet. 2017;390(10113):2673-2734. https://doi.org/10.1016/S0140-6736(17)31363-6
  3. Parfenov VA, Zaharov VV, Preobrazenskaya IS. Kognitivnyye rasstroystva. M.: Remedium; 2014. (In Russ.).
  4. Luriya AR. Osnovy neyropsikhologii. M.: Izdatel’skiy tsentr «Akademiya»; 2013. (In Russ.).
  5. Cummings JL. Frontal-subcortical circuits and human behavior. Arch Neurol. 1993;50:873-880. 
  6. Povedenchiskaya nevrologiya. Pod red. Zakharova V.V. SPb.: Skifiya-print; M.: Profmedpress; 2022. (In Russ.).
  7. Cristofori I, Cohen-Zimerman S, Grafman J. Executive functions, Editor(s): D’Esposito M, Grafman JH, Handbook of Clinical Neurology. Elsevier. 2019;163:197-219. 
  8. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Diseases. Fifth Edition. (DSM-V). London. 2013. https://www.psy-chiatry.org/psychiatrists/practice/dsm
  9. Tabeeva GR. Neyrokognitivnoye stareniye i kognitivnye rasstroystva. S.S. Korsakov Journal of Neurology and Psichiatry. 2019;119(6):160-167. (In Russ.). https://doi.org/10.17116/jnevro2019119061160
  10. Salthouse T. Consequences of age-related cognitive declines. Annl Rev Psychol. 2012;63:201-226.  https://doi.org/10.1146/annurev-psych-120710-100328
  11. Sachdev P, Kalaria R, O’Brien J, et al. Diagnostic criteria for vascular cognitive disorders: a VASCOG statement. Alzheimer Dis Assoc Disord. 2014;28(3):206-218. 
  12. McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7(3):263-269.  https://doi.org/10.1016/j.jalz.2011.03.005
  13. Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12(8):822-838.  https://doi.org/10.1016/S1474-4422(13)70124-8
  14. Kognitivnye rasstroystva u lits pozhilogo i starcheskogo vozrasta: klinicheskiye rekomendatsii. M.: Minzdrav Rossii; 2020. (In Russ.).
  15. Pinto TCC, Machado L, Bulgacov TM, et al. Is the Montreal Cognitive Assessment (MoCA) screening superior to the Mini-Mental State Examination (MMSE) in the detection of mild cognitive impairment (MCI) and Alzheimer’s Disease (AD) in the elderly? Int Psychogeriatr. 2019;31(4):491-504.  https://doi.org/10.1017/S1041610218001370
  16. Korsakova NK, Moskovichyute LI. Klinicheskaya neyropsikhologiya. M.: MGU; 1988. (In Russ.).
  17. Cummings JL. Frontal-subcortical circuits and human behavior. Arch Neurol. 1993;50:873-880. 
  18. Zakharov VV. Hronicheskaya tserebrovaskulyarnaya nedostatochnost’. M.: MEDpress-inform; 2016. (In Russ.).
  19. Verdelho A, Goncalves-Pereira M. Neuropsychiatric symptoms of cognitive impairment and dementia. neuropsychiatric symptoms of neurological disease. Springer: Springer International Publishing Switzerland; 2016.
  20. Yahno NN, Zaharov VV, Lokshina AB, et.al. Dementsii: rukovodstvo dlya vrachey. M.: MEDpress-inform. 2011. (In Russ.).
  21. Pantoni L, Fierini F, Poggesi A; LADIS Study Group. Impact of cerebral white matter changes on functionality in older adults: An overview of the LADIS Study results and future directions. Geriatr Gerontol Int. 2015;15(suppl 1):10-16.  https://doi.org/10.1111/ggi.12665

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.